SCHEMBL13660416

SCHEMBL13660416

O=c1c2ncccc2nc([C@@H]2C[C@@H]3C[C@@H]3C2)n1-c1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.42
PDE4B Q07343 5/20 0.40
PDE4D Q08499 3/20 0.40
DRD1 P21728 2/20 0.37
DRD5 P21918 2/20 0.37
TSHR P16473 2/20 0.37
MAPK1 P28482 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
GAA P10253 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13660310 0.88 HRH3 (0.42) HRH3PDE4BPDE4DTSHRMEN1
SCHEMBL13660456 0.87 HRH3 (0.40) HRH3PDE4BPDE4DDRD1DRD5
SCHEMBL13660412 0.87 HRH3 (0.40) HRH3PDE4BPDE4DDRD1DRD5
SCHEMBL3185944 0.81 PDE4B (0.39) HRH3PDE4BPDE4DDRD1DRD5
SCHEMBL3185951 0.81 PDE4B (0.39) HRH3PDE4BPDE4DDRD1DRD5
SCHEMBL13660460 0.81 PDE4B (0.39) HRH3PDE4BPDE4DDRD1DRD5
SCHEMBL13660459 0.81 PDE4B (0.46) HRH3PDE4BPDE4DTSHRUSP14
SCHEMBL13660307 0.80 HRH3 (0.41) HRH3PDE4BPDE4DDRD1DRD5
SCHEMBL1993198 0.79 PDE4B (0.44) HRH3PDE4BPDE4DTSHRMAPK1
SCHEMBL13660461 0.76 HRH3 (0.37) HRH3PDE4BPDE4DRAB9AUSP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009121036-A2 SUBSTITUTED ARYL PYRIMIDINONE DERIVATIVES NEUROGEN CORPORATION (US) 2009-10-01 WO disclosed